LCTX logo

Lineage Cell Therapeutics (LCTX) Operating Margin

Annual Operating Margin

-276.50%
-123.33%-80.52%

31 December 2023

LCTX Operating Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Margin

-101.61%
+315.08%+75.61%

30 September 2024

LCTX Quarterly Operating Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LCTX Operating Margin Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-80.5%+81.1%
3 y3 years+91.9%+67.3%
5 y5 years+90.5%+97.4%

LCTX Operating Margin High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-80.5%+91.9%-9.3%+96.5%
5 y5 years-80.5%+91.9%-9.3%+98.4%
alltimeall time-136.6%+100.0%-120.8%+100.0%

Lineage Cell Therapeutics Operating Margin History

DateAnnualQuarterly
Sept 2024
-
-101.61%(-75.6%)
June 2024
-
-416.69%(-9.7%)
Mar 2024
-
-461.29%(+51.4%)
Dec 2023
-276.50%(+80.5%)
-304.69%(-43.4%)
Sept 2023
-
-538.12%(+245.4%)
June 2023
-
-155.78%(-44.0%)
Mar 2023
-
-278.37%(-19.7%)
Dec 2022
-153.17%(-87.9%)
-346.68%(+97.9%)
Sept 2022
-
-175.15%(+88.4%)
June 2022
-
-92.99%(-23.9%)
Mar 2022
-
-122.13%(-95.8%)
Dec 2021
-1263.12%(-63.1%)
-2941.46%(+846.5%)
Sept 2021
-
-310.76%(-80.6%)
June 2021
-
-1605.44%(-33.3%)
Mar 2021
-
-2406.14%(-32.1%)
Dec 2020
-3421.35%(+30.1%)
-3543.37%(+80.2%)
Sept 2020
-
-1966.37%(-69.6%)
June 2020
-
-6466.67%(+44.3%)
Mar 2020
-
-4480.72%(+442.5%)
Dec 2019
-2630.31%(-9.1%)
-825.96%(-78.7%)
Sept 2019
-
-3881.11%(-10.3%)
June 2019
-
-4328.40%(-39.3%)
Mar 2019
-
-7129.05%(+19.3%)
Dec 2018
-2895.13%(+27.6%)
-5973.68%(+52.3%)
Sept 2018
-
-3923.11%(+160.0%)
June 2018
-
-1508.91%(-50.3%)
Mar 2018
-
-3036.53%(+80.7%)
Dec 2017
-2268.75%(-13.4%)
-1680.67%(-18.2%)
Sept 2017
-
-2054.64%(-24.1%)
June 2017
-
-2708.14%(-8.9%)
Mar 2017
-
-2971.50%(+100.2%)
Dec 2016
-2618.43%(+0.8%)
-1484.56%(-39.4%)
Sept 2016
-
-2450.00%(-13.9%)
June 2016
-
-2846.44%(-29.8%)
Mar 2016
-
-4054.27%(+3.7%)
Dec 2015
-2597.04%(-0.2%)
-3909.91%(+92.0%)
Sept 2015
-
-2036.19%(-13.7%)
June 2015
-
-2359.44%(-1.3%)
Mar 2015
-
-2389.73%(-26.2%)
Dec 2014
-2603.08%(+93.3%)
-3236.18%(+44.8%)
Sept 2014
-
-2235.36%(-20.1%)
June 2014
-
-2797.00%(+23.3%)
Mar 2014
-
-2268.51%(+141.6%)
Dec 2013
-1346.63%(-8.8%)
-939.03%(-49.0%)
Sept 2013
-
-1842.74%(+18.7%)
June 2013
-
-1552.36%(-2.9%)
Mar 2013
-
-1598.77%(+17.4%)
Dec 2012
-1476.82%(+31.7%)
-1362.18%(+28.7%)
Sept 2012
-
-1058.26%(-37.1%)
June 2012
-
-1683.43%(-28.5%)
Mar 2012
-
-2352.99%(-580.7%)
Dec 2011
-1120.98%(+56.1%)
489.49%(-234.3%)
Sept 2011
-
-364.37%(-42.9%)
June 2011
-
-638.29%(+30.7%)
Mar 2011
-
-488.21%(-215.7%)
Dec 2010
-718.25%(+292.8%)
422.05%(-240.0%)
Sept 2010
-
-301.45%(-11.4%)
June 2010
-
-340.36%(+97.3%)
Mar 2010
-
-172.53%(-73.7%)
Dec 2009
-182.86%(-2.6%)
-
Sept 2009
-
-656.46%(+156.1%)
June 2009
-
-256.35%(-16.5%)
Mar 2009
-
-307.09%(-9.5%)
Dec 2008
-187.70%
-339.32%(+58.5%)
Sept 2008
-
-214.05%(-7.4%)
DateAnnualQuarterly
June 2008
-
-231.23%(+116.4%)
Mar 2008
-
-106.84%(+48.8%)
Dec 2007
-116.85%(-22.5%)
-71.79%(+6.6%)
Sept 2007
-
-67.34%(-51.7%)
June 2007
-
-139.41%(-33.6%)
Mar 2007
-
-209.86%(+196.2%)
Dec 2006
-150.76%(-32.5%)
-70.85%(-32.0%)
Sept 2006
-
-104.21%(-76.7%)
June 2006
-
-447.77%(+134.8%)
Mar 2006
-
-190.73%(-8.2%)
Dec 2005
-223.47%(-21.9%)
-207.73%(+23.7%)
Sept 2005
-
-167.91%(-2.0%)
June 2005
-
-171.37%(-54.9%)
Mar 2005
-
-379.69%(+21.6%)
Dec 2004
-286.00%(-5.8%)
-312.24%(+27.9%)
Sept 2004
-
-244.13%(+6.5%)
June 2004
-
-229.32%(-40.7%)
Mar 2004
-
-386.76%(+161.3%)
Dec 2003
-303.70%(-42.2%)
-148.02%(-54.5%)
Sept 2003
-
-325.22%(-35.8%)
June 2003
-
-506.57%(+5.1%)
Mar 2003
-
-481.96%(+44.9%)
Dec 2002
-525.72%(-77.1%)
-332.55%(-10.1%)
Sept 2002
-
-369.97%(-60.8%)
June 2002
-
-942.72%(+0.9%)
Mar 2002
-
-934.29%(+14.0%)
Dec 2001
-2300.33%(-76.3%)
-819.28%(-68.1%)
Sept 2001
-
-2565.05%(-31.7%)
June 2001
-
-3756.68%(+28.2%)
Mar 2001
-
-2930.71%(+47.9%)
Dec 2000
-9697.25%(+1646.8%)
-1981.93%(-100.0%)
Sept 2000
-
-128.57 M%(>+9900.0%)
June 2000
-
-18.57 K%(-22.9%)
Mar 2000
-
-24.07 K%(+518.3%)
Dec 1999
-555.15%(-100.0%)
-3892.56%(-100.0%)
Sept 1999
-
-240.00 M%(>+9900.0%)
June 1999
-
-183.33%(-8.3%)
Mar 1999
-
-200.00%(-83.3%)
Dec 1998
-240.00 M%(>+9900.0%)
-
Sept 1998
-
-1200.00%(+1100.0%)
June 1998
-
-100.00%(-91.7%)
June 1998
-317.39%(-90.1%)
-
Mar 1998
-
-1200.00%(+433.3%)
Dec 1997
-
-225.00%(-79.5%)
Sept 1997
-
-1100.00%(+120.0%)
June 1997
-3200.00%(+60.0%)
-
Mar 1997
-
-500.00%(-28.6%)
Dec 1996
-
-700.00%(+16.7%)
Sept 1996
-
-600.00%(+50.0%)
June 1996
-2000.00%(-20.0%)
-
Sept 1995
-
-400.00%(-20.0%)
June 1995
-2500.00%(+56.3%)
-
Mar 1995
-
-500.00%(-16.7%)
Dec 1994
-
-600.00%(+50.0%)
Sept 1994
-
-400.00%(+100.0%)
June 1994
-1600.00%(+23.1%)
-
Mar 1994
-
-200.00%(-33.3%)
Dec 1993
-
-300.00%(0.0%)
Sept 1993
-
-300.00%(+50.0%)
June 1993
-1300.00%(+85.7%)
-
Mar 1993
-
-200.00%(-33.3%)
Dec 1992
-
-300.00%(+50.0%)
Sept 1992
-
-200.00%(+100.0%)
June 1992
-700.00%
-
Mar 1992
-
-100.00%

FAQ

  • What is Lineage Cell Therapeutics annual operating profit margin?
  • What is the all time high annual operating margin for Lineage Cell Therapeutics?
  • What is Lineage Cell Therapeutics annual operating margin year-on-year change?
  • What is Lineage Cell Therapeutics quarterly operating profit margin?
  • What is the all time high quarterly operating margin for Lineage Cell Therapeutics?
  • What is Lineage Cell Therapeutics quarterly operating margin year-on-year change?

What is Lineage Cell Therapeutics annual operating profit margin?

The current annual operating margin of LCTX is -276.50%

What is the all time high annual operating margin for Lineage Cell Therapeutics?

Lineage Cell Therapeutics all-time high annual operating profit margin is -116.85%

What is Lineage Cell Therapeutics annual operating margin year-on-year change?

Over the past year, LCTX annual operating profit margin has changed by -123.33% (-80.52%)

What is Lineage Cell Therapeutics quarterly operating profit margin?

The current quarterly operating margin of LCTX is -101.61%

What is the all time high quarterly operating margin for Lineage Cell Therapeutics?

Lineage Cell Therapeutics all-time high quarterly operating profit margin is 489.49%

What is Lineage Cell Therapeutics quarterly operating margin year-on-year change?

Over the past year, LCTX quarterly operating profit margin has changed by +436.51% (+81.12%)